Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018.

Wouters OJ, McKee M, Luyten J.

JAMA. 2020 Mar 3;323(9):844-853. doi: 10.1001/jama.2020.1166.

PMID:
32125404
2.

Cost Considerations Within a Duty of Beneficence.

Luyten J.

Am J Bioeth. 2020 Mar;20(3):79-81. doi: 10.1080/15265161.2020.1714802. No abstract available.

PMID:
32116174
3.

Electrodeposition of indium from the ionic liquid trihexyl(tetradecyl)phosphonium chloride.

Deferm C, Malaquias JC, Onghena B, Banerjee D, Luyten J, Oosterhof H, Fransaer J, Binnemans K.

Green Chem. 2019 Mar 21;21(6):1517-1530. doi: 10.1039/c8gc03389g. Epub 2019 Feb 28.

4.

Ethical Considerations for Movement Mapping to Identify Disease Transmission Hotspots.

de Jong BC, Gaye BM, Luyten J, van Buitenen B, André E, Meehan CJ, O'Siochain C, Tomsu K, Urbain J, Grietens KP, Njue M, Pinxten W, Gehre F, Nyan O, Buvé A, Roca A, Ravinetto R, Antonio M.

Emerg Infect Dis. 2019 Jul;25(7). doi: 10.3201/eid2507.181421.

5.

Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument.

Luyten J, Bruyneel L, van Hoek AJ.

Vaccine. 2019 Apr 24;37(18):2494-2501. doi: 10.1016/j.vaccine.2019.03.041. Epub 2019 Mar 30.

PMID:
30940484
6.

Quantifying the public's view on social value judgments in vaccine decision-making: A discrete choice experiment.

Luyten J, Kessels R, Atkins KE, Jit M, van Hoek AJ.

Soc Sci Med. 2019 May;228:181-193. doi: 10.1016/j.socscimed.2019.03.025. Epub 2019 Mar 20.

PMID:
30925392
7.

Methodological Challenges in the Economic Evaluation of Occupational Health and Safety Programmes.

Steel J, Godderis L, Luyten J.

Int J Environ Res Public Health. 2018 Nov 21;15(11). pii: E2606. doi: 10.3390/ijerph15112606.

8.

Pain Complaints in Patients Undergoing Orthognathic Surgery.

Agbaje J, Luyten J, Politis C.

Pain Res Manag. 2018 Jul 15;2018:4235025. doi: 10.1155/2018/4235025. eCollection 2018.

9.

Productivity estimation in economic evaluations of occupational health and safety interventions: a systematic review.

Steel J, Godderis L, Luyten J.

Scand J Work Environ Health. 2018 Sep 1;44(5):458-474. doi: 10.5271/sjweh.3715. Epub 2018 Feb 6.

PMID:
29405241
10.

Cost-effectiveness of ovarian stimulation with gonadotrophin and clomiphene citrate in an intrauterine insemination programme for subfertile couples.

Peeraer K, Luyten J, Tomassetti C, Verschueren S, Spiessens C, Tanghe A, Meuleman C, Debrock S, Dancet E, D'Hooghe T.

Reprod Biomed Online. 2018 Mar;36(3):302-310. doi: 10.1016/j.rbmo.2017.12.007. Epub 2017 Dec 27.

PMID:
29395750
11.

Thermal stability of trihexyl(tetradecyl)phosphonium chloride.

Deferm C, Van den Bossche A, Luyten J, Oosterhof H, Fransaer J, Binnemans K.

Phys Chem Chem Phys. 2018 Jan 24;20(4):2444-2456. doi: 10.1039/c7cp08556g.

PMID:
29313045
12.

Economic evaluation of occupational health services: necessary, challenging and promising.

Luyten J, Steel J, Godderis L.

Occup Environ Med. 2017 Nov;74(11):847-848. doi: 10.1136/oemed-2017-104495. Epub 2017 Sep 12. No abstract available.

PMID:
28899965
13.

Speciation of indium(iii) chloro complexes in the solvent extraction process from chloride aqueous solutions to ionic liquids.

Deferm C, Onghena B, Vander Hoogerstraete T, Banerjee D, Luyten J, Oosterhof H, Fransaer J, Binnemans K.

Dalton Trans. 2017 Mar 27;46(13):4412-4421. doi: 10.1039/c7dt00618g.

PMID:
28294262
14.

'Egocentric' Vaccination: The Authors Reply.

Luyten J, Beutels P.

Health Aff (Millwood). 2016 May 1;35(5):937. doi: 10.1377/hlthaff.2016.0371. No abstract available.

PMID:
27141002
15.

Economic evaluation of mental health interventions: an introduction to cost-utility analysis.

Luyten J, Naci H, Knapp M.

Evid Based Ment Health. 2016 May;19(2):49-53. doi: 10.1136/eb-2016-102354. Epub 2016 Apr 13. Review.

PMID:
27075444
16.

The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness.

Luyten J, Beutels P.

Health Aff (Millwood). 2016 Feb;35(2):212-8. doi: 10.1377/hlthaff.2015.1088.

PMID:
26858372
17.

A Modular Approach To Study Protein Adsorption on Surface Modified Hydroxyapatite.

Ozhukil Kollath V, Van den Broeck F, Fehér K, Martins JC, Luyten J, Traina K, Mullens S, Cloots R.

Chemistry. 2015 Jul 13;21(29):10497-505. doi: 10.1002/chem.201500223. Epub 2015 Jun 10.

PMID:
26096378
18.

Public preferences for prioritizing preventive and curative health care interventions: a discrete choice experiment.

Luyten J, Kessels R, Goos P, Beutels P.

Value Health. 2015 Mar;18(2):224-33. doi: 10.1016/j.jval.2014.12.007.

19.

Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives.

Luyten J, Ogunjimi B, Beutels P.

Vaccine. 2014 Dec 12;32(52):7175-8. doi: 10.1016/j.vaccine.2014.10.015. Epub 2014 Oct 25.

PMID:
25454883
20.

Screening for potential co-products in a Miscanthus sinensis mapping family by liquid chromatography with mass spectrometry detection.

Parveen I, Wilson T, Threadgill MD, Luyten J, Roberts RE, Robson PR, Donnison IS, Hauck B, Winters AL.

Phytochemistry. 2014 Sep;105:186-96. doi: 10.1016/j.phytochem.2014.05.003. Epub 2014 Jun 2.

PMID:
24894362
21.

AOX removal from industrial wastewaters using advanced oxidation processes: assessment of a combined chemical-biological oxidation.

Luyten J, Sniegowski K, Van Eyck K, Maertens D, Timmermans S, Liers S, Braeken L.

Water Sci Technol. 2013;68(9):2048-54. doi: 10.2166/wst.2013.459.

PMID:
24225107
22.

The sexual ethics of HPV vaccination for boys.

Luyten J, Engelen B, Beutels P.

HEC Forum. 2014 Mar;26(1):27-42. doi: 10.1007/s10730-013-9219-z.

PMID:
23907594
23.

Kicking against the pricks: vaccine sceptics have a different social orientation.

Luyten J, Desmet P, Dorgali V, Hens N, Beutels P.

Eur J Public Health. 2014 Apr;24(2):310-4. doi: 10.1093/eurpub/ckt080. Epub 2013 Jun 28.

PMID:
23813706
24.

Public preferences over efficiency, equity and autonomy in vaccination policy: an empirical study.

Luyten J, Dorgali V, Hens N, Beutels P.

Soc Sci Med. 2013 Jan;77:84-9. doi: 10.1016/j.socscimed.2012.11.009. Epub 2012 Nov 16.

PMID:
23218439
25.

Cost-effectiveness of hepatitis A vaccination for adults in Belgium.

Luyten J, Van de Sande S, de Schrijver K, Van Damme P, Beutels P.

Vaccine. 2012 Sep 14;30(42):6070-80. doi: 10.1016/j.vaccine.2012.07.049. Epub 2012 Aug 2.

PMID:
22858555
26.

Implantable (bio)polymer coated titanium scaffolds: a review.

Vanderleyden E, Mullens S, Luyten J, Dubruel P.

Curr Pharm Des. 2012;18(18):2576-90. Review.

PMID:
22512448
27.

Differential sensitivity of coral larvae to natural levels of ultraviolet radiation during the onset of larval competence.

Aranda M, Banaszak AT, Bayer T, Luyten JR, Medina M, Voolstra CR.

Mol Ecol. 2011 Jul;20(14):2955-72. doi: 10.1111/j.1365-294X.2011.05153.x. Epub 2011 Jun 20.

PMID:
21689186
28.

Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis a patients.

Luyten J, Marais C, Hens N, De Schrijver K, Beutels P.

Value Health. 2011 Mar-Apr;14(2):282-90. doi: 10.1016/j.jval.2010.10.004. Epub 2011 Feb 5.

29.

Vancomycin release from poly(D,L-lactic acid) spray-coated hydroxyapatite fibers.

Ravelingien M, Mullens S, Luyten J, D'Hondt M, Boonen J, De Spiegeleer B, Coenye T, Vervaet C, Remon JP.

Eur J Pharm Biopharm. 2010 Nov;76(3):366-70. doi: 10.1016/j.ejpb.2010.08.010. Epub 2010 Sep 9.

PMID:
20816957
30.

Evaluation of bone regeneration with an injectable, in situ polymerizable Pluronic F127 hydrogel derivative combined with autologous mesenchymal stem cells in a goat tibia defect model.

Lippens E, Vertenten G, Gironès J, Declercq H, Saunders J, Luyten J, Duchateau L, Schacht E, Vlaminck L, Gasthuys F, Cornelissen M.

Tissue Eng Part A. 2010 Feb;16(2):617-27. doi: 10.1089/ten.TEA.2009.0418.

PMID:
19743958
31.

Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A.

Luyten J, Beutels P.

Pharmacoeconomics. 2009;27(5):379-89. doi: 10.2165/00019053-200927050-00003. Review.

PMID:
19586076
32.

Quantitative screening of engineered implants in a long bone defect model in rabbits.

Bakker AD, Schrooten J, van Cleynenbreugel T, Vanlauwe J, Luyten J, Schepers E, Dubruel P, Schacht E, Lammens J, Luyten FP.

Tissue Eng Part C Methods. 2008 Sep;14(3):251-60. doi: 10.1089/ten.tec.2008.0022.

PMID:
18781837
33.

Porous hydroxyapatite tablets as carriers for low-dosed drugs.

Cosijns A, Vervaet C, Luyten J, Mullens S, Siepmann F, Van Hoorebeke L, Masschaele B, Cnudde V, Remon JP.

Eur J Pharm Biopharm. 2007 Sep;67(2):498-506. Epub 2007 Feb 28.

PMID:
17407810
34.

A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder.

Janssen RJ, Wevers RA, Häussler M, Luyten JA, Steenbergen-Spanjers GC, Hoffmann GF, Nagatsu T, Van den Heuvel LP.

Ann Hum Genet. 2000 Sep;64(Pt 5):375-82.

35.

Genetic variation in ICF syndrome: evidence for genetic heterogeneity.

Wijmenga C, Hansen RS, Gimelli G, Björck EJ, Davies EG, Valentine D, Belohradsky BH, van Dongen JJ, Smeets DF, van den Heuvel LP, Luyten JA, Strengman E, Weemaes C, Pearson PL.

Hum Mutat. 2000 Dec;16(6):509-17. Review.

PMID:
11102980
36.

Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis.

Verrips A, Nijeholt GJ, Barkhof F, Van Engelen BG, Wesseling P, Luyten JA, Wevers RA, Stam J, Wokke JH, van den Heuvel LP, Keyser A, Gabreëls FJ.

Brain. 1999 Aug;122 ( Pt 8):1589-95.

PMID:
10430841
37.

Localization of the ICF syndrome to chromosome 20 by homozygosity mapping.

Wijmenga C, van den Heuvel LP, Strengman E, Luyten JA, van der Burgt IJ, de Groot R, Smeets DF, Draaisma JM, van Dongen JJ, De Abreu RA, Pearson PL, Sandkuijl LA, Weemaes CM.

Am J Hum Genet. 1998 Sep;63(3):803-9.

38.

Genetic characteristics of myoadenylate deaminase deficiency.

Verzijl HT, van Engelen BG, Luyten JA, Steenbergen GC, van den Heuvel LP, ter Laak HJ, Padberg GW, Wevers RA.

Ann Neurol. 1998 Jul;44(1):140-3.

PMID:
9667605
39.

Exon skipping in the sterol 27-hydroxylase gene leads to cerebrotendinous xanthomatosis.

Verrips A, Steenbergen-Spanjers GC, Luyten JA, Wevers RA, Wokke JH, Gabreëls FJ, Wolthers BG, van den Heuvel LP.

Hum Genet. 1997 Aug;100(2):284-6.

PMID:
9254865
40.

Two new mutations in the sterol 27-hydroxylase gene in two families lead to cerebrotendinous xanthomatosis.

Verrips A, Steenbergen-Spanjers GC, Luyten JA, van den Heuvel LP, Keyser A, Gabreëls FJ, Wevers RA.

Hum Genet. 1996 Dec;98(6):735-7.

PMID:
8931710
41.

Primary progressive hemiparesis.

Linn FH, Luyten JA, Van Gijn J, Jansen GH.

J Neurol Neurosurg Psychiatry. 1995 Sep;59(3):339-40. No abstract available.

42.

Metachromatic leukodystrophy: a 12-bp deletion in exon 2 of the arylsulfatase A gene in a late infantile variant.

Luyten JA, Wenink PW, Steenbergen-Spanjers GC, Wevers RA, Ploos van Amstel HK, de Jong JG, van den Heuvel LP.

Hum Genet. 1995 Sep;96(3):357-60.

PMID:
7649558
43.

Equatorial currents in the Western Indian ocean.

Luyten JR, Fieux M, Gonella J.

Science. 1980 Aug 1;209(4456):600-3.

PMID:
17756843
44.

Analysis of steroids by high-resolution gas-liquid chromatography. II. Application to urinary samples.

Luyten JA, Rutten GA.

J Chromatogr. 1974 Apr 24;91:393-406. No abstract available.

PMID:
4833128
45.
46.

Analysis of steroids by high resolution gas-liquid chromatography. I. Preparation of apolar columns.

Rutten GA, Luyten JA.

J Chromatogr. 1972 Dec 20;74(2):177-93. No abstract available.

PMID:
4264854

Supplemental Content

Loading ...
Support Center